Skip to main content

Ipamorelin Release

Meaning

Ipamorelin Release describes the physiological event of enhanced Growth Hormone (GH) secretion from the anterior pituitary gland following the administration of the synthetic peptide Ipamorelin. Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) that functions as a ghrelin mimetic. This targeted release mechanism is clinically advantageous because it stimulates GH in a pulsatile, natural manner without significantly increasing the release of cortisol, prolactin, or other pituitary hormones. The goal of this release is to improve body composition, support tissue repair, and enhance overall vitality by elevating circulating GH and IGF-1 levels.